Lorraine Goldstein
Marvin's wife, Lorraine


April 12,1999

Dear Dr. Snady:

The following notes outline the diagnosis, treatment and subsequent history of the pancreatic cancer experienced by my wife, Lorraine. Presently, Lorraine is 65 years old and was 63 when initially diagnosed.

On April 16, 1997, Lorraine was diagnosed and treated for a duodenal ulcer here in New Jersey by gastroenterologist Dr. Thomas Fiest. Our family physician, Dr. Kenneth Granet, did follow-up medical checks, blood work and other testing. On July 11, 1997, during a follow-up examination, Dr. Granet noticed Lorraine had a jaundiced, yellow complexion. As a result, he had her admitted to a local hospital for stabilization and diagnoses. During that time, she was diagnosed as having pancreatic cancer.

On July 15, 1997, Dr. Granet had Lorraine transferred to Mt. Sinai Hospital in New York City under the care of Dr. Howard Bruckner, a neoplastic oncologist, where she remained until July 24, 1997. During this time she underwent a series of tests and had a stent surgically implanted. On July 29, 1997, Dr. Bruckner referred Lorraine to Harry Snady, MD, Ph.D. at his office in New York.

Dr. Snady did an endoscopic ultrasonography procedure on Lorraine. After completing the procedure, Dr. Snady explained Lorraine's problem to me using diagrams to illustrate the size, location and dimension of the affected area, a large mass in the area of the pancreas. He completely explained the seriousness of her illness and the ramifications of pancreatic cancer and the possibility of surgery if Dr. Bruckner could reduce the tumor through chemical treatment first. With patience and using terms that a layman would readily grasp, Dr. Snady enabled me to fully understand the scope and gravity of the situation.

In August, 1997, under the care of Dr. Howard Bruckner, Lorraine started her chemotherapy and radiation treatments at Mt. Sinai Hospital. The first week consisted of five days of chemotherapy and radiation as an inpatient. The second week was five days of radiation administered to my wife as an outpatient. The following two weeks allowed for Lorraine to rest at home. This regimen continued for three months through October, 1997. As could be expected by the medical professionals, the treatment took its toll on Lorraine. Unfortunately, even though it was explained to us, we were not prepared for this ordeal.

Dr. Bruckner then had Lorraine see Dr. Snady once again at his New York office on October 30. 1997. Dr. Snady performed another endoscopic ultrasonography procedure and then illustrated and explained to me that Lorraine had a major reduction of her tumor due to her treatments by Dr. Bruckner. We took the report from Dr. Snady that evening and went to Dr. Bruckner who was waiting for us in his office at Mt. Sinai.

After reviewing the results of Lorraine's test, he informed us that she would begin a regimen of fifty three hours of chemotherapy a month, three and a half days at a time at Mt. Sinai (November and December) on an inpatient basis.

Because I was diagnosed as having prostate cancer and had a radical prostatectomy in January, 1998, Lorraine's treatment was extended through January and February to March, 1998. Dr. Bruckner decided that if I had surgery first then I would be able to better care for Lorraine after her surgery.

After Lorraine finished her treatments, Dr. Bruckner had Lorraine see Dr. Avram Cooperman, a surgeon specializing in pancreatic surgery, in his New York office. After an examination and consultation Dr. Cooperman made an appointment for Lorraine to see Dr. Anouk Stem at Beth Israel Hospital in New York for a three dimensional CAT Scan. After the CAT Scan we had a short meeting with Dr. Stem who said she couldn't detect any tumor during the test.

On March 2, 1998, Dr. Cooperman performed Whipple surgery on Lorraine at Community Hospital in Dobbs Ferry, New York. Afterwards, Dr. Cooperman said the surgery was successful and that he didn't see any tumor during surgery. On March 12, 1998, Lorraine was discharged from the hospital.

On March 23, 1998, under the care of Dr. Howard Bruckner, Lorraine began a new phase of chemotherapy treatments: every four weeks in Mt. Sinai Hospital, three and a half day session for a total of fifty-three hours of chemotherapy. These treatments continued through the months of April, May and June. All of Lorraine's treatments were planned and calculated by Dr. Howard Bruckner.

For the next nine months, there was constant testing on a weekly basis. Each week there was blood work done. Every two months her port was flushed and blood was taken for a tumor marker. Every three months a three dimensional CAT Scan was taken. In March, 1998, Lorraine was informed that her testing would be less frequent, down to a three-month frequency.

At the present time, Lorraine lives a normal life, free, of treatments and is in reasonably good health. She is about seventy-five pounds lighter than she was in July, 1997, when first diagnosed with the disease; the start of her nightmare.

Marvin Goldstein

Related Papers by Dr. Snady
EUS: An Effective New Tool for GI Tumors

Artifacts and Techniques of EUS

Role of EUS in Outcome of GI Diseases

Survival Advantage of Combined Multimodal Therapy (CMT) for Pancreatic Carcinoma

Survival After CMT for Pancreatic Cancer

Influence of CMT on UnResectable Pancreatic Cancer

Can EUS Influence Outcome of Pancreatic Cancer?
»French version

Identification of Major Vascular Anatomy with EUS
»French version

Staging of Pancreatic Masses

EUS Criteria of Vascular Invasion

EUS Compared w/CT plus ERCP

© 1999 EUS Imaging, P.C., All rights reserved.